|
|
Article: Research and Markets: U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market From 2004 to 2014.
- Article from:
- Business Wire
- Article date:
- June 4, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/4bf5fd/u_s_biotechnology) has announced the addition of Frost & Sullivan's new report "U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market" to their offering.
This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, organ transplantation, cardiovascular disorders, infectious diseases, and other ...